Goldenwell Biotech (Goldenwell Biotech) Gross-Profit-to-Asset % : 0.00% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Goldenwell Biotech Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Goldenwell Biotech's annualized Gross Profit for the quarter that ended in Mar. 2024 was $0.00 Mil. Goldenwell Biotech's average Total Assets over the quarter that ended in Mar. 2024 was $0.21 Mil. Therefore, Goldenwell Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 0.00%.

Goldenwell Biotech Gross-Profit-to-Asset % Historical Data

The historical data trend for Goldenwell Biotech's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goldenwell Biotech Gross-Profit-to-Asset % Chart

Goldenwell Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

2.25

7.05

0.42

Goldenwell Biotech Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial										1.71	-	-	-	-

Competitive Comparison of Goldenwell Biotech's Gross-Profit-to-Asset %

For the Packaged Foods subindustry, Goldenwell Biotech's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Goldenwell Biotech's Gross-Profit-to-Asset % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Goldenwell Biotech's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Goldenwell Biotech's Gross-Profit-to-Asset % falls into.

Goldenwell Biotech Gross-Profit-to-Asset % Calculation

Goldenwell Biotech's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	0.001	/	( (0.248	+	0.228)	/ 2 )
	=	0.001	/	0.238
	=	0.42 %

Goldenwell Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	0	/	( (0.228	+	0.199)	/ 2 )
	=	0	/	0.2135
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Goldenwell Biotech Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Goldenwell Biotech's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Goldenwell Biotech (Goldenwell Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Goldenwell Biotech Inc (OTCPK:GWLL) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2071 Midway Drive, Twinsburg, OH, USA, 44087

Website

https://www.goldenwellbiotech.com

Goldenwell Biotech Inc is engaged in the research and development, production and sales of health care and supplements products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.

Executives

Li Yang	director, 10 percent owner, officer: Treasurer	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087
Hua Xie	director, officer: Secretary	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087
Shuang Liu	director, 10 percent owner, officer: Chief Executive Officer	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087

Goldenwell Biotech (Goldenwell Biotech) Headlines

No Headlines